现代中西医结合杂志
現代中西醫結閤雜誌
현대중서의결합잡지
MODERN JOURNAL OF INTEGRATED TRADITIONAL CHINESE AND WESTERN MEDICINE
2014年
12期
1276-1278
,共3页
崔海滨%葛怀娥%白希永%魏晓楠%付冬霞
崔海濱%葛懷娥%白希永%魏曉楠%付鼕霞
최해빈%갈부아%백희영%위효남%부동하
胃癌%胃肠道重建%2型糖尿病%胰岛功能
胃癌%胃腸道重建%2型糖尿病%胰島功能
위암%위장도중건%2형당뇨병%이도공능
gastric cancer%digestive tract reconstruction%type 2 diabetes mellitus%pancreatic β-cell function
目的:探讨胃癌根治术不同胃肠道重建方式对合并2型糖尿病患者血糖变化及胰岛β细胞功能的影响。方法选择行根治性手术治疗的48例胃癌合并2型糖尿病患者,根据胃肠道重建方式分为2组,A组35例行BillrothⅠ式吻合术,B组13例行Roux-en-Y胃肠转流术,比较2组患者术前及术后3,6个月的体质量指数( BMI)、糖化血红蛋白(HbA1c)、空腹血糖(FBG)、空腹胰岛素(FINS)、空腹C肽(FC-P)的水平,检测并比较口服75 g葡萄糖2 h后的血糖(2hPG)、胰岛素(2hINS)及C肽(2hC-P)水平,采用稳态模式评估法评价胰岛素抵抗指数(HOMA-IR)。结果 A组术后BMI、HOMA-IR、FBG、2hPG、FINS、2hINS、FC-P和2hC-P水平与术前比较无明显变化;术后3个月A组HbA1c水平较术前显著下降(P<0.05)。 B组术后BMI虽无明显变化,但FBG、2hPG、HbA1c水平及HOMA-IR较术前显著下降(P均<0.05),FINS及2hINS、FC-P及2hC-P较术前明显升高(P均<0.01)。结论采用Roux-en-Y吻合重建能有效降低胃癌合并2型糖尿病患者的血糖水平,明显改善胰岛β细胞功能。
目的:探討胃癌根治術不同胃腸道重建方式對閤併2型糖尿病患者血糖變化及胰島β細胞功能的影響。方法選擇行根治性手術治療的48例胃癌閤併2型糖尿病患者,根據胃腸道重建方式分為2組,A組35例行BillrothⅠ式吻閤術,B組13例行Roux-en-Y胃腸轉流術,比較2組患者術前及術後3,6箇月的體質量指數( BMI)、糖化血紅蛋白(HbA1c)、空腹血糖(FBG)、空腹胰島素(FINS)、空腹C肽(FC-P)的水平,檢測併比較口服75 g葡萄糖2 h後的血糖(2hPG)、胰島素(2hINS)及C肽(2hC-P)水平,採用穩態模式評估法評價胰島素牴抗指數(HOMA-IR)。結果 A組術後BMI、HOMA-IR、FBG、2hPG、FINS、2hINS、FC-P和2hC-P水平與術前比較無明顯變化;術後3箇月A組HbA1c水平較術前顯著下降(P<0.05)。 B組術後BMI雖無明顯變化,但FBG、2hPG、HbA1c水平及HOMA-IR較術前顯著下降(P均<0.05),FINS及2hINS、FC-P及2hC-P較術前明顯升高(P均<0.01)。結論採用Roux-en-Y吻閤重建能有效降低胃癌閤併2型糖尿病患者的血糖水平,明顯改善胰島β細胞功能。
목적:탐토위암근치술불동위장도중건방식대합병2형당뇨병환자혈당변화급이도β세포공능적영향。방법선택행근치성수술치료적48례위암합병2형당뇨병환자,근거위장도중건방식분위2조,A조35례행BillrothⅠ식문합술,B조13례행Roux-en-Y위장전류술,비교2조환자술전급술후3,6개월적체질량지수( BMI)、당화혈홍단백(HbA1c)、공복혈당(FBG)、공복이도소(FINS)、공복C태(FC-P)적수평,검측병비교구복75 g포도당2 h후적혈당(2hPG)、이도소(2hINS)급C태(2hC-P)수평,채용은태모식평고법평개이도소저항지수(HOMA-IR)。결과 A조술후BMI、HOMA-IR、FBG、2hPG、FINS、2hINS、FC-P화2hC-P수평여술전비교무명현변화;술후3개월A조HbA1c수평교술전현저하강(P<0.05)。 B조술후BMI수무명현변화,단FBG、2hPG、HbA1c수평급HOMA-IR교술전현저하강(P균<0.05),FINS급2hINS、FC-P급2hC-P교술전명현승고(P균<0.01)。결론채용Roux-en-Y문합중건능유효강저위암합병2형당뇨병환자적혈당수평,명현개선이도β세포공능。
Objective It is to approach the influence of different techniques for gastrointestinal tract reconstruction on blood glucose and pancreatic β-cell function in gastric cancer patients with type 2 diabetes.Methods 48 gastric cancer pa-tients with type 2 diabetes were selected and divided into two groups according to different alimentary tract reconstruction , Group A with 35 cases were treated by Billroth I anastomosis and Group B with 13 cases were treated by Roux-en-Y anasto-mosis.Both groups were subjected to the measuring of preoperative and postoperative third , sixth months The values of body mass index (BMI), glycosylated hemoglobin (HbA1c), fasting blood glucose (FBG), fasting insulin (FINS) and C-pep-tide (FC-P) were compared;the levels of 2 hour blood glucose (2hPG), insulin (2hINS) and C-peptide (2hC-P) in o-ral glucose tolerance ( OGTT) were observed and compared .The homeostasis model ( HOMA) was adopted to estimate the in-dex of insulin resistance (IR).Results There were no significant difference in levels of BMI , FBG, FINS, FC-P, 2hPG, 2hINS, 2hC-P and HOMA-IR between before and after operation in Group A (all P>0.05);while the value of HBA1c at postoperative third month was markedly decreased compared to preoperative (P<0.05).The BMI in Group B has no change compared before operation , but there were significant differences in the levels of FBG , 2hPG, HbA1c and HOMA-IR after operation three and six months in Group B , postoperative third , sixth months and there were very significant differences in the values of FINS, FC-P, 2hINS and 2hC-P between before and after operation (P<0.05).Conclusion Roux-en-Y gas-tric bypass can effectively decrease blood glucose level and improve pancreatic β-cell function in gastric cancer patients with type 2 diabetes .